Madan H. Jagasia, MBBS, MS, MMHC - Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Go online to PeerView.com/XYM860 to view the entire program with slides. This activity utilizes a “CaseBook” format, offering learners a collection of patient case scenarios from the experts’ personal repertoire paired with analyses of how the treatment landscape in acute and chronic graft-versus-host disease (GVHD) is evolving. Hematology-oncology and bone marrow transplant professionals take a deep dive into the underlying immunology of GVHD and the latest evidence with innovative therapeutics while also obtaining expert perspectives on the practical application of these advancements as prophylaxis or for treatment...
Source: PeerView CME/CE Audio Podcast - Immunology - April 5, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Molecular Testing & AML
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Molecular Testing & AML. At The 60th ASH Annual Meet...
Author: obr
Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Current Maintenance Regimens For MM
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Current Maintenance Regimens For MM. At The 60th ASH...
Author: obr
Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts
The POLLUX & CASTOR Clinical Studies
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses The POLLUX & CASTOR Clinical Studies. At The 60th AS...
Author: obr
Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Anti-BCMA CAR-T Cell Therapy In MM
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Anti-BCMA CAR-T Cell Therapy In MM. At The 60th ASH ...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Outcomes Of The TOURMALINE-MM3 Study
Ravi Vij, MD Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Dr. Vij Shares Data Regarding His Clinical Trial Presented At ASH 2018
Ravi Vij, MD Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine Discusses Data Regarding His Clinical Trial Presented At ASH 201...
Author: obr
Added: 01/11/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 12, 2019 Category: Cancer & Oncology Source Type: podcasts
How much do bone marrow transplants really cost?
Prakash Satwani, MD, of Columbia University Medical Center, New York, NY, speaks to us about the true cost of bone marrow transplant ,and highlights potential alterations to the process and alternativ...
Author: VJHemOnc
Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts
Transplantation clinical trial network to build available prospective studies on AML
With the remarkable success of the US Bone Marrow Transplant Clinical Trials Network (BMT CNT), founded by Mary Horowitz, in running successful prospective transplantation clinical trials, it is only ...
Author: VJHemOnc
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Case study: acquired von Willebrand disease in allogeneic BMT
Acquired von Willebrand disease is a rare condition that has been reported in post-autologous bone marrow transplant (BMT) patients, though never in post-allogeneic BMT. Here, HaemSTAR Co-lead Pip Nic...
Author: VJHemOnc
Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Launching Phase 2 Trial In Multi-Center Fashion & #124; Currently Evaluated in Bone Marrow Transplantation
Aman Chauhan, MBBS, University of Kentucky shares Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation
Aman Chauhan, MBBS, University of Kentucky shares Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Giving attention to the needs and voices of bone and marrow transplant patients
Blood and bone marrow transplantation continues to experience breakthroughs, with the role of the patient becoming increasingly important. In this talk, Anita Waldmann from the Leukaemia Patient-Suppo...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating GvHD: current challenges and newly approved drugs
Graft versus host disease (GvHD) remains to be one of the leading causes of morbidity and mortality in patients who have undergone bone marrow transplant. Here, Katie Gatwood, PharmD, BCOP, of Vanderb...
Author: VJHemOnc
Added: 04/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Physiologic Frailty in Hematopoietic Cell Transplantation Patients (JAMA Oncology)
Interview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 2, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts